Interestingly, when tumors were derived from BR-MM cells, the combined treatment with SI-2 and BTZ remarkably suppressed or even halted tumor growth in most cases (Fig. 7a) and, moreover, significantly improved mouse survival (Fig. 7b). This evidence concerns the gene CASC3 and Miyoshi myopathy.